Institutional Ownership Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). We have compiled data on the 153 institutions that hold shares in the stock, with a total of 132 Million shares, which have been reported (via 13F filing form) to have a value of $678 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Zurcher Kantonalbank (Zurich Cantonalbank)
Zurich, V8 |
May 07, 2025 Q1 2025 |
4,205
shares
|
$20,688
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
National Bank Of Canada
|
May 12, 2025 Q1 2025 |
3,233
shares
|
$15,906
0.0% of portfolio
|
Q1 2025
Reduced 95.68%
|
|
|
Us Bancorp \De\
|
May 08, 2025 Q1 2025 |
3,004
shares
|
$14,779
0.0% of portfolio
|
Q1 2025
Added 53.58%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
2,920
shares
|
$14,366
0.0% of portfolio
|
Q1 2025
Added 22.12%
|
|
|
Parallel Advisors, LLC
|
Jul 07, 2025 Q2 2025 |
2,688
shares
|
$13,224
0.0% of portfolio
|
Q2 2025
Reduced 19.01%
|
|
|
Global Retirement Partners, LLC
|
Jan 31, 2025 Q4 2024 |
2,000
shares
|
$9,840
0.0% of portfolio
|
Q1 2024
Added 380.77%
|
|
|
Principal Securities, Inc.
Des Moines, IA |
Apr 30, 2025 Q1 2025 |
1,433
shares
|
$7,050
0.0% of portfolio
|
Q4 2024
Reduced 2.45%
|
|
|
Daiwa Securities Group Inc.
Tokyo, M0 |
May 13, 2025 Q1 2025 |
1,151
shares
|
$5,662
0.0% of portfolio
|
Q4 2022
Added 8.58%
|
|
|
Lindbrook Capital, LLC
|
May 05, 2025 Q1 2025 |
1,011
shares
|
$4,974
0.0% of portfolio
|
Q1 2025
Reduced 87.97%
|
|
|
Allworth Financial LP
|
Apr 30, 2025 Q1 2025 |
902
shares
|
$4,437
0.0% of portfolio
|
Q1 2025
Reduced 29.64%
|
|
|
Nisa Investment Advisors, LLC
|
Apr 30, 2025 Q1 2025 |
610
shares
|
$3,001
0.0% of portfolio
|
Q4 2023
Reduced 8.96%
|
|
|
Baystate Wealth Management LLC
|
Jan 29, 2024 Q4 2023 |
500
shares
|
$2,460
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
May 15, 2025 Q1 2025 |
300
shares
|
$1,476
0.0% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
|
Jones Financial Companies Lllp
|
May 28, 2025 Q1 2025 |
200
shares
|
$984
0.0% of portfolio
|
Q1 2025
Reduced 82.74%
|
|
|
Parkside Financial Bank & Trust
|
May 08, 2025 Q1 2025 |
200
shares
|
$984
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Trustcore Financial Services, LLC
|
Feb 13, 2023 Q4 2022 |
161
shares
|
$792
0.0% of portfolio
|
Q4 2021
Reduced 66.53%
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
135
shares
|
$664
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Continuum Advisory, LLC
Eagle, ID |
Apr 22, 2025 Q1 2025 |
93
shares
|
$457
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
75
shares
|
$369
0.0% of portfolio
|
Q2 2021
Added 400.0%
|
|
|
Dcvc Bio Gp, LLC
Palo Alto, CA |
Nov 14, 2022 Q3 2022 |
0
shares
|
$0
100.0% of portfolio
|
Q3 2022
Closed
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|